Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor

Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and many targeted anti-cancer drugs that have been tested clinically, the success rate for these agents in the clinic is low, particularly in terms of the improvement of overall survival. Intratumoral hetero...

Full description

Bibliographic Details
Main Authors: Weitsman, Gregory, Mitchell, Nicholas J., Evans, Rachel, Cheung, Anthony, Kalber, Tammy L., Bofinger, Robin, Fruhwirth, Gilbert O., Keppler, Melanie, Wright, Zoe V. F., Barber, Paul R., Gordon, Peter, Koning, Tamra de, Wulaningsih, Wahyu, Sander, Kerstin, Vojnovic, Borivoj, Hailes, Helen C., Tabor, Alethea B., Ng, Tony
Format: Article
Published: Nature Publishing Group 2017
Online Access:https://eprints.nottingham.ac.uk/40932/
_version_ 1848796165610405888
author Weitsman, Gregory
Mitchell, Nicholas J.
Evans, Rachel
Cheung, Anthony
Kalber, Tammy L.
Bofinger, Robin
Fruhwirth, Gilbert O.
Keppler, Melanie
Wright, Zoe V. F.
Barber, Paul R.
Gordon, Peter
Koning, Tamra de
Wulaningsih, Wahyu
Sander, Kerstin
Vojnovic, Borivoj
Hailes, Helen C.
Tabor, Alethea B.
Ng, Tony
author_facet Weitsman, Gregory
Mitchell, Nicholas J.
Evans, Rachel
Cheung, Anthony
Kalber, Tammy L.
Bofinger, Robin
Fruhwirth, Gilbert O.
Keppler, Melanie
Wright, Zoe V. F.
Barber, Paul R.
Gordon, Peter
Koning, Tamra de
Wulaningsih, Wahyu
Sander, Kerstin
Vojnovic, Borivoj
Hailes, Helen C.
Tabor, Alethea B.
Ng, Tony
author_sort Weitsman, Gregory
building Nottingham Research Data Repository
collection Online Access
description Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and many targeted anti-cancer drugs that have been tested clinically, the success rate for these agents in the clinic is low, particularly in terms of the improvement of overall survival. Intratumoral heterogeneity is proposed as a major mechanism underlying treatment failure of these molecule-targeted agents. Here we highlight the application of fluorescence lifetime microscopy (FLIM)-based biosensing to demonstrate intratumoral heterogeneity of EGFR activity. For sensing EGFR activity in cells, we used a genetically encoded CrkII-based biosensor which undergoes conformational changes upon tyrosine-221 phosphorylation by EGFR. We transfected this biosensor into EGFR-positive tumour cells using targeted lipopolyplexes bearing EGFR-binding peptides at their surfaces. In a murine model of basal-like breast cancer, we demonstrated a significant degree of intratumoral heterogeneity in EGFR activity, as well as the pharmacodynamic effect of a radionuclide-labeled EGFR inhibitor in situ. Furthermore, a significant correlation between high EGFR activity in tumour cells and macrophage-tumour cell proximity was found to in part account for the intratumoral heterogeneity in EGFR activity observed. The same effect of macrophage infiltrate on EGFR activation was also seen in a colorectal cancer xenograft. In contrast, a non-small cell lung cancer xenograft expressing a constitutively active EGFR conformational mutant exhibited macrophage proximity-independent EGFR activity. Our study validates the use of this methodology to monitor therapeutic response in terms of EGFR activity. In addition, we found iNOS gene induction in macrophages that are cultured in tumour cell-conditioned media as well as an iNOS activity-dependent increase in EGFR activity in tumour cells. These findings point towards an immune microenvironment-mediated regulation that gives rise to the observed intratumoral heterogeneity of EGFR signalling activity in tumour cells in vivo.
first_indexed 2025-11-14T19:43:39Z
format Article
id nottingham-40932
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:43:39Z
publishDate 2017
publisher Nature Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-409322020-05-04T18:35:55Z https://eprints.nottingham.ac.uk/40932/ Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor Weitsman, Gregory Mitchell, Nicholas J. Evans, Rachel Cheung, Anthony Kalber, Tammy L. Bofinger, Robin Fruhwirth, Gilbert O. Keppler, Melanie Wright, Zoe V. F. Barber, Paul R. Gordon, Peter Koning, Tamra de Wulaningsih, Wahyu Sander, Kerstin Vojnovic, Borivoj Hailes, Helen C. Tabor, Alethea B. Ng, Tony Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and many targeted anti-cancer drugs that have been tested clinically, the success rate for these agents in the clinic is low, particularly in terms of the improvement of overall survival. Intratumoral heterogeneity is proposed as a major mechanism underlying treatment failure of these molecule-targeted agents. Here we highlight the application of fluorescence lifetime microscopy (FLIM)-based biosensing to demonstrate intratumoral heterogeneity of EGFR activity. For sensing EGFR activity in cells, we used a genetically encoded CrkII-based biosensor which undergoes conformational changes upon tyrosine-221 phosphorylation by EGFR. We transfected this biosensor into EGFR-positive tumour cells using targeted lipopolyplexes bearing EGFR-binding peptides at their surfaces. In a murine model of basal-like breast cancer, we demonstrated a significant degree of intratumoral heterogeneity in EGFR activity, as well as the pharmacodynamic effect of a radionuclide-labeled EGFR inhibitor in situ. Furthermore, a significant correlation between high EGFR activity in tumour cells and macrophage-tumour cell proximity was found to in part account for the intratumoral heterogeneity in EGFR activity observed. The same effect of macrophage infiltrate on EGFR activation was also seen in a colorectal cancer xenograft. In contrast, a non-small cell lung cancer xenograft expressing a constitutively active EGFR conformational mutant exhibited macrophage proximity-independent EGFR activity. Our study validates the use of this methodology to monitor therapeutic response in terms of EGFR activity. In addition, we found iNOS gene induction in macrophages that are cultured in tumour cell-conditioned media as well as an iNOS activity-dependent increase in EGFR activity in tumour cells. These findings point towards an immune microenvironment-mediated regulation that gives rise to the observed intratumoral heterogeneity of EGFR signalling activity in tumour cells in vivo. Nature Publishing Group 2017-02-06 Article PeerReviewed Weitsman, Gregory, Mitchell, Nicholas J., Evans, Rachel, Cheung, Anthony, Kalber, Tammy L., Bofinger, Robin, Fruhwirth, Gilbert O., Keppler, Melanie, Wright, Zoe V. F., Barber, Paul R., Gordon, Peter, Koning, Tamra de, Wulaningsih, Wahyu, Sander, Kerstin, Vojnovic, Borivoj, Hailes, Helen C., Tabor, Alethea B. and Ng, Tony (2017) Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor. Oncogene . ISSN 0950-9232 http://www.nature.com/onc/journal/vaop/ncurrent/full/onc2016522a.html doi:10.1038/onc.2016.522 doi:10.1038/onc.2016.522
spellingShingle Weitsman, Gregory
Mitchell, Nicholas J.
Evans, Rachel
Cheung, Anthony
Kalber, Tammy L.
Bofinger, Robin
Fruhwirth, Gilbert O.
Keppler, Melanie
Wright, Zoe V. F.
Barber, Paul R.
Gordon, Peter
Koning, Tamra de
Wulaningsih, Wahyu
Sander, Kerstin
Vojnovic, Borivoj
Hailes, Helen C.
Tabor, Alethea B.
Ng, Tony
Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
title Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
title_full Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
title_fullStr Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
title_full_unstemmed Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
title_short Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
title_sort detecting intratumoral heterogeneity of egfr activity by liposome-based in vivo transfection of a fluorescent biosensor
url https://eprints.nottingham.ac.uk/40932/
https://eprints.nottingham.ac.uk/40932/
https://eprints.nottingham.ac.uk/40932/